Experimental ADHD drug tested on teens in classroom setting
NCT ID NCT06215144
Summary
This study tested whether a medication called NRCT-101SR could help control ADHD symptoms in teenagers aged 13-17. Researchers compared the drug against a placebo (inactive treatment) over 12 weeks, measuring changes in ADHD symptoms using standard rating scales. The trial was terminated early and did not complete its planned enrollment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accel Research Sites - Lakeland Clinical Research Unit
Lakeland, Florida, 33803, United States
-
Accel Research Sites Network - Maitland
Maitland, Florida, 32751, United States
-
Advanced Research Center, Inc
Anaheim, California, 92805, United States
-
Bio-Medical Research LLC
Miami, Florida, 33144, United States
-
Boston Clinical Trials Llc
Boston, Massachusetts, 02131, United States
-
CenExel ACMR Atlanta Center for Medical Research
Atlanta, Georgia, 30331, United States
-
CenExel iRS - iResearch Savannah
Savannah, Georgia, 31405, United States
-
Coastal Carolina Research Center - North Charleston
North Charleston, South Carolina, 29405, United States
-
DelRicht Research
New Orleans, Louisiana, 70155, United States
-
DelRicht Research
Prairieville, Louisiana, 70769, United States
-
Epic Medical Research - DeSoto
DeSoto, Texas, 75115, United States
-
Vector Clinical Trials
Las Vegas, Nevada, 89128, United States
-
iResearch Atlanta
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.